EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives

Andrea Costamagna, Giulia Milan, Maria Chiara De Santis, Alessandro Carrer, Miriam Martini

Trends in Endocrinology & Metabolism · 2026-10 · 37 (10) · 977-992

DOI: 10.1016/j.tem.2026.03.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-10. Verfasst von Andrea Costamagna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Torino 10126, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Lipid Metabolism, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pezcoller Foundation, AIRC Foundation for Cancer Research, Ministero dell'Istruzione dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, driven by aggressive biology, profound therapy resistance, and scarce treatment options. Beyond classical metabolic rewiring, recent discoveries reveal that lipid metabolism plays a central and previously underappreciated role in PDAC progression. Emerging evidence shows that fatty acids, cholesterol, lysophospholipids, sphingolipids, and oxidized lipid species actively shape oncogenic signaling, influence stromal and immune interactions, and contribute to metastasis and treatment evasion. In this review, we highlight these recent advances and discuss how lipid-driven circuits intersect with major oncogenic pathways, including KRAS effectors and phosphoinositide 3-kinase-AKT. By integrating mechanistic insights with therapeutic perspectives, we outline new opportunities to exploit lipid-based vulnerabilities in pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsLipid MetabolismCarcinoma, Pancreatic DuctalHumansSignal TransductionAnimalsDisease Progression

Stichwörter der Autor:innen

lipid metabolic rewiringlipid signalingoncogenic pathwayspancreatic ductal adenocarcinomatherapy resistancetumor–stroma interactions

Autor:innen und Institutionen

  • Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Torino 10126, Italy.
  • Veneto Institute of Molecular Medicine (VIMM), Padova, Italy; Department of Biology, University of Padova, Padova, Italy.
  • Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Torino 10126, Italy. Electronic address: miriam.martini@unito.it.

Förderung

  • Pezcoller Foundation
  • AIRC Foundation for Cancer Research
  • Ministero dell'Istruzione dell'Università e della Ricerca
  • Fondazione Nadia Valsecchi
  • CRT Foundation
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Costamagna, A., Milan, G., De Santis, M. C., Carrer, A., & Martini, M. (2026). Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends in Endocrinology & Metabolism, 37(10), 977-992. https://doi.org/10.1016/j.tem.2026.03.004

Vancouver

Costamagna A, Milan G, De Santis MC, Carrer A, Martini M. Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends in Endocrinology & Metabolism. 2026;37(10):977-992. doi:10.1016/j.tem.2026.03.004

BibTeX
@article{Costamagna2026,
  author = {Costamagna, Andrea and Milan, Giulia and De Santis, Maria Chiara and Carrer, Alessandro and Martini, Miriam},
  title = {Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2026},
  volume = {37},
  number = {10},
  pages = {977--992},
  doi = {10.1016/j.tem.2026.03.004}
}
Kostenlos starten →